RVT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
RVT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Royce Value Trust's Asset Impairment Charge for the six months ended in Jun. 2024 was $0.0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2024 was $0.0 Mil.
The historical data trend for Royce Value Trust's Asset Impairment Charge can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Royce Value Trust Annual Data | ||||||||||||||||
Trend | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||
Asset Impairment Charge | Get a 7-Day Free Trial | - | - | - | - | - |
Royce Value Trust Semi-Annual Data | ||||||||||||||
Dec17 | Jun18 | Dec18 | Jun19 | Dec19 | Jun20 | Dec20 | Jun21 | Dec21 | Jun22 | Dec22 | Jun23 | Dec23 | Jun24 | |
Asset Impairment Charge | Get a 7-Day Free Trial | - | - | - | - | - |
Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.
Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.0 Mil.
Thank you for viewing the detailed overview of Royce Value Trust's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.
Christopher D Clark | officer: Vice President, other: President - Investment Advisor | 745 FIFTH AVENUE, SUITE 2400, NEW YORK NY 10151 |
Francis Gannon | officer: Vice President | C/O ROYCE & ASSOCIATES, LLC, 745 FIFTH AVENUE, NEW YORK NY 10151 |
Julia Ward Poston | director | C/O ROYCE & ASSOCIATES, 745 FIFTH AVENUE, SUITE 2300, NEW YORK NY 10151 |
Christopher C. Grisanti | director | 745 FIFTH AVENUE, SUITE 2300, NEW YORK NY 10151 |
G Peter Obrien | director | C/O ROYCE & ASSOCIATES, LLC, 745 FIFTH AVENUE, NEW YORK NY 10151 |
Michael K. Shields | director | C/O ROYCE & ASSOCIATES, LLC, 745 FIFTH AVENUE, SUITE 2300, NEW YORK NY 10151 |
Cecile Burleigh Harper | director | C/O ROYCE & ASSOCIATES, 745 FIFTH AVENUE, SUITE 2300, NEW YORK NY 10151 |
Peter K Hoglund | officer: Treasurer, other: CFO Investment Advisor | 745 FIFTH AVENUE, SUITE 2300, NEW YORK NY 10151 |
O Byrne Daniel A | officer: Vice President, other: VP - Investment Advisor | ROYCE & ASSOCIATES, 745 FIFTH AVENUE, NEW YORK NY 10151 |
Charles M Royce | director, officer: President, other: Pres./Dir.- Investment Adviser | C/O ROYCE & ASSOCIATES, LLC, 745 FIFTH AVENUE, NEW YORK NY 10151 |
Stephen L Isaacs | director | C/O ROYCE & ASSOCIATES, LLC, 745 FIFTH AVENUE, NEW YORK NY 10151 |
John E Denneen | officer: Secretary, other: Secretary-Investment Adviser | C/O ROYCE & ASSOCIATES LLC, 745 FIFTH AVENUE, NEW YORK NY 10151 |
Arthur S Mehlman | director | C/O ROYCE & ASSOCIATES, 745 FIFTH AVENUE, NEW YORK NY 10151 |
Richard M Galkin | director, other: Director through 2/26/2016. | C/O ROYCE & ASSOCIATES, LLC, 745 FIFTH AVENUE, NEW YORK NY 10151 |
John D Diederich | officer: Vice President & Treasurer, other: COO & CFO - Investment Adviser | ROYCE & ASSOCIATES LLC, 745 FIFTH AVENUE, NEW YORK NY 10151 |
From GuruFocus
By PRNewswire PRNewswire • 06-01-2023
By PRNewswire • 09-27-2024
By GuruFocus Research • 12-08-2023
By PRNewswire • 07-27-2023
By PRNewswire • 11-20-2024
By PRNewswire • 12-28-2023
By PRNewswire • 10-03-2023
By PRNewswire • 03-01-2024
By PRNewswire • 09-03-2024
By PRNewswire • 10-30-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.